Osmotica Pharmaceuticals plc to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference

Rhea-AI Summary

Osmotica Pharmaceuticals (Nasdaq: OSMT) announced that CEO Brian Markison and CFO Andrew Einhorn will present at the RBC Capital Markets Global Healthcare Virtual Conference. The event is scheduled for May 19, 2020, at 9:10 a.m. Eastern Time. Interested individuals can access the live webcast and archived presentation through Osmotica's website under the Investor & News section. Osmotica focuses on developing specialty products targeting underserved patient populations and operates in the United States, Argentina, and Hungary.

News Market Reaction – OSMT

+0.52%

+0.52% Session move

In the trading session that priced this news, OSMT gained 0.52%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRIDGEWATER, N.J., May 13, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and Andrew Einhorn, Chief Financial Officer, will present at the RBC Capital Markets Global Healthcare Virtual Conference as follows:

Date:	Tuesday, May 19, 2020
Time:	9:10 a.m. Eastern Time
Webcast:	https://www.veracast.com/webcasts/rbc/healthcare2020/18103270999.cfm

The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.osmotica.com under the “Investor & News” section.

About Osmotica Pharmaceuticals plc

Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories, LLC represents the non-promoted products including complex generic formulations.

Osmotica has operations in the United States, Argentina, and Hungary.

Investor and Media Relations for Osmotica Pharmaceuticals plc
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com 

 

FAQ

When is Osmotica Pharmaceuticals' presentation at the RBC Capital Markets Global Healthcare Conference?

Osmotica Pharmaceuticals will present on May 19, 2020, at 9:10 a.m. Eastern Time.

Where can I watch the Osmotica Pharmaceuticals presentation?

The presentation can be viewed live and archived on Osmotica's website under the Investor & News section.

Who will be presenting for Osmotica Pharmaceuticals at the conference?

CEO Brian Markison and CFO Andrew Einhorn will be presenting at the conference.

What does Osmotica Pharmaceuticals focus on?

Osmotica Pharmaceuticals focuses on the development and commercialization of specialty products for underserved patient populations.

In which countries does Osmotica Pharmaceuticals operate?

Osmotica Pharmaceuticals has operations in the United States, Argentina, and Hungary.